QR kód

Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Obesity is in epidemic proportions in many parts of the world, contributing to increasing rates of non-alcoholic fatty liver disease (NAFLD). NAFLD represents a range of conditions from the initial stage of fatty liver to non-alcoholic steatohepatitis (NASH), which can progress to severe fibrosis, t...

Celý popis

Uloženo v:
Hlavní autoři: Tharani Senavirathna, Armaghan Shafaei, Ricky Lareu, Lois Balmer
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2024-04-01
Edice:Antioxidants
Témata:
ellagic acid
urolithins
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
dietarily interventions
On-line přístup:https://www.mdpi.com/2076-3921/13/4/485
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky